Finboldยท2025-09-14 18:52Group 1: Eli Lilly (NYSE: LLY) - Eli Lilly is positioned as a key player in the weight-loss and diabetes treatment market, with significant sales growth driven by its drugs Mounjaro and Zepbound [2] - The company benefits from a defensive sector positioning, as healthcare spending remains resilient during economic downturns [3] - Despite its potential, Eli Lilly's stock has shown volatility in 2025, dropping 3% year-to-date to trade at $755 [3] Group 2: Broadcom (NASDAQ: AVGO) - Broadcom is a major player in the artificial intelligence and cloud infrastructure sectors, with its chips powering essential networking and wireless systems [5] - The stock has gained 55% year-to-date, trading at $359, reflecting its resilience in 2025 [5] - Broadcom's $69 billion acquisition of VMware diversifies its revenue streams and enhances its cash flow, appealing to income-seeking investors [7] - Long-term demand drivers from AI and data centers provide Broadcom with a solid growth outlook for 2025 and beyond, despite integration risks and semiconductor cyclicality [8]